Chronic Myeloid Leukemia clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
open to eligible people ages 18 years and up
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Orange, California
Our lead scientists for Chronic Myeloid Leukemia research studies include Mahtab Jafari.
Last updated: